The management of renal osteodystrophy.
Hyperparathyroidism is the main cause of renal bone disease. At the moment its progress can be retarded by controlling plasma calcium and phosphate. But the prevention and cure of hyperparathyroidism without surgery eludes us. There is a suggestion that the administration of some metabolite of Vitamin D may be more successful. Osteomalacia on the other hand does not appear to be an important problem and is easily prevented and cured.
D000534:Alum Compounds / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000517:prevention & control / Q000628:therapy*; D004032:Diet; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000628:therapy; D010018:Osteomalacia / Q000517:prevention & control / Q000628:therapy; D010280:Parathyroid Glands / Q000601:surgery; D010710:Phosphates / Q000378:metabolism; D006435:Renal Dialysis; D013965:Thyroidectomy
D000534:Alum Compounds; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010710:Phosphates; D002116:Calcitonin; D002118:Calcium